Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ACAD | ACADIA PHARMACEUTICALS INC | CEO, Director | $4.05M | -$2.85M | -41.3% | Aug 16, 2024 |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Director | $112K | Dec 16, 2022 | ||
BLCM | BELLICUM PHARMACEUTICALS, INC | Director | Jan 3, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|